Who owns the REDESIGNER DRUGS trademark?

The REDESIGNER DRUGS trademark is owned by Reviva Pharmaceuticals, Inc..

What class is the REDESIGNER DRUGS trademark registered in?

The REDESIGNER DRUGS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for REDESIGNER DRUGS?

The USPTO serial number for REDESIGNER DRUGS is 77166972.

What is the registration number for REDESIGNER DRUGS?

REDESIGNER DRUGS is registered under USPTO registration number 0.

Sealvo

Home Search: REDESIGNER DRUGSREDESIGNER DRUGS #77166972

Back

Updated Oct 27, 2026·12 searches this week

View on USPTO TSDR Find similar marks

RED

USPTO Trademark Record

ABANDONED

REDESIGNER DRUGS

SN 77166972·Reg 0·Filed Apr 26, 2007

Owner Reviva Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

REDESIGNER DRUGS (Serial No. 77166972), Registration No. 0, is a abandoned US trademark filed on Apr 26, 2007 by Reviva Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

REDESIGNER DRUGS (Reg. #0) is an abandoned US trademark that was filed in 2007 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 26, 2007

SERIAL

77166972

REG#

Filing Information

StatusABANDONED

Filing DateApr 26, 2007

Serial Number77166972

Registration No.0

Status DateAug 02, 2010

Published for OppositionApr 08, 2008

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

27 events

ABANDONMENT - NO USE STATEMENT FILED

Aug 02, 2010

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Aug 02, 2010

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

SOU EXTENSION 3 GRANTED

Jan 07, 2010

SOU EXTENSION 3 GRANTED

SOU TEAS EXTENSION RECEIVED

Jan 04, 2010

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Jan 01, 2010

SOU EXTENSION 3 FILED

SOU EXTENSION 2 GRANTED

Jul 01, 2009

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Jun 29, 2009

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jun 29, 2009

SOU EXTENSION 2 FILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 14, 2009

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 GRANTED

Jan 14, 2009

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Dec 30, 2008

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 30, 2008

SOU EXTENSION 1 FILED

NOA MAILED - SOU REQUIRED FROM APPLICANT

Jul 01, 2008

NOA MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 08, 2008

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Mar 19, 2008

NOTICE OF PUBLICATION

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 06, 2008

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Mar 03, 2008

ASSIGNED TO LIE

EXAMINERS AMENDMENT -WRITTEN

Feb 07, 2008

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Feb 07, 2008

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 07, 2008

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Feb 07, 2008

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 07, 2008

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Aug 09, 2007

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Aug 09, 2007

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 09, 2007

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 09, 2007

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

May 01, 2007

NEW APPLICATION ENTERED

Other Marks by Reviva Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

REV

REVIVA

77166973

Reviva Pharmaceuticals, Inc.

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

LON

LONDON DRUGS

86668903

London Drugs Limited

REGISTERED

DRU

DRUGS AMERICA

73784600

MAST DRUG CO., INC.

REGISTERED

ALG

ALGORITHMS AS DRUGS

98669553

Primordial AI Inc.

REGISTERED

LET

LET'S DISCOVER DRUGS TOGETHER

98028262

Biolexis Therapeutics

REGISTERED

Other Marks by Connie L. Ellerbach, Esq.

Additional USPTO filings handled by the same attorney of record.

DEA

DEALPATH

86982382

REGISTERED

CHI

CHILDREN SHOULD BE SEEN & HEARD

88849315

REGISTERED

CHI

CHILDREN SHOULD BE SEEN & HEARD

88979442

REGISTERED

EVE

EVERSENSE

86695085

REGISTERED

REDESIGNER DRUGS

Run a conflict check

Other Marks by Reviva Pharmaceuticals, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Connie L. Ellerbach, Esq.

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company